RESUMEN
Reimmunization guidelines have recommended the inactivated HAV vaccine for hematopoietic stem cell transplant (HSCT) recipients living in or traveling to areas where hepatitis A is endemic. As a shift from high to medium hepatitis A endemicity has been observed in several countries in Latin America, we conducted a retrospective study to evaluate the prevalence of hepatitis A pre-bone marrow transplant (BMT) and the loss of specific antibodies in consecutive stored serum samples from 77 BMT recipients followed up from 82 to 1530 days. The prevalence of HAV antibodies was 92.2% before BMT. As vaccine was not available in Brazil when the samples were taken, it was assumed that this prevalence reflects natural infection. Survival analysis showed that the probability of becoming seronegative was 4.5% (+/-2.6%), 7.9% (+/-3.4%), 10.1% (+/-4.0%), 23.4% (+/-9.6%) at 1, 2, 3 and 4 years after transplant, respectively. The loss of HAV antibodies was significantly associated with longer follow-up (P=0.0015), younger age (P=0.049) and acute graft-versus-host disease (P=0.035). As most reimmunization protocols start around day +365, in developing countries with similar HAV endemicity, BMT recipients should have serological screening before HAV vaccination and the inactivated vaccine should be advised to those seronegative.
Asunto(s)
Formación de Anticuerpos , Trasplante de Médula Ósea/efectos adversos , Anticuerpos de Hepatitis A/sangre , Adolescente , Adulto , Formación de Anticuerpos/inmunología , Brasil/epidemiología , Niño , Preescolar , Estudios de Seguimiento , Hepatitis A/sangre , Hepatitis A/epidemiología , Humanos , Persona de Mediana Edad , Prevalencia , Estudios Retrospectivos , Factores de Riesgo , Estudios Seroepidemiológicos , Pruebas Serológicas , Análisis de SupervivenciaRESUMEN
Human herpesvirus-8 (HHV-8) appears to be transmitted mainly by sexual contact. However, several studies suggest that in developing countries the infection may be acquired early in life by routes other than sexual transmission. The present study estimated the seroprevalence of HHV-8 in Brazilian children born to HIV-1-infected mothers. The serum samples were collected in a cross-sectional cohort study from 99 children born to HIV-infected mothers (median age 3.27 years; range 1.5-13.8 years) attending the outpatient clinic of the Federal University of Sao Paulo. IgG antibodies to HHV-8 latency-associated nuclear antigen and lytic phase antigens were detected by immunofluorescence assays. The samples tested were collected from children aged 12 months or older to exclude the possibility of cross-placental antibody transport. The total prevalence of anti-lytic antibodies in this population (5/99; 5%) reveals that HHV-8 infection can occur during childhood. Children aged 1.5 to 2 years had a seroprevalence of 2% (1/50) and children aged 3.25 to 13.8 years had a seroprevalence of 8% (4/49). This difference was not statistically significant, probably because of the small size of the sample, but it suggests that HHV-8 infection occurs more commonly late in infancy. Further prospective studies are necessary to evaluate the timing and risk factors for primary HHV-8 infection in the pediatric population.
Asunto(s)
Infecciones por VIH/complicaciones , VIH-1/inmunología , Infecciones por Herpesviridae/epidemiología , Herpesvirus Humano 8/inmunología , Complicaciones Infecciosas del Embarazo/virología , Adolescente , Brasil/epidemiología , Niño , Preescolar , Métodos Epidemiológicos , Femenino , Técnica del Anticuerpo Fluorescente Directa , Anticuerpos Anti-VIH/sangre , Infecciones por Herpesviridae/diagnóstico , Infecciones por Herpesviridae/transmisión , Infecciones por Herpesviridae/virología , Humanos , Inmunoglobulina G/sangre , Lactante , Transmisión Vertical de Enfermedad Infecciosa , Masculino , EmbarazoRESUMEN
Measles vaccination has been recommended after the second year following bone marrow transplant (BMT) in patients not receiving immunosuppressive drugs. During a measles outbreak, we vaccinated all patients after the first year of transplant, and conducted a prospective trial to evaluate safety, effectiveness and sustained immunity after early vaccination. Patients received attenuated virus vaccine between 9 and 18 months after BMT. A total of 51 patients were evaluated and 27 of them (52.9%) were receiving immunosuppressive drugs. Only mild adverse reactions were noted. Nine patients (17.6%) were susceptible (IgG< or =100 mIU/ml) at vaccination, and all seroconverted. In those immune at vaccination, a four-fold increase in measles IgG titers was found in one of 34 patients (2.9%) with specific IgG> or =200 mIU/ml compared to 14 of 17 (82.3%) with IgG<200 mIU/ml (P< 0.0001). Sustained immunity after 24 months was more likely to occur in patients with specific IgG levels< or =200 or > or =500 mIU/mL (83.4 and 100%, respectively) in comparison to patients with 200Asunto(s)
Trasplante de Médula Ósea/efectos adversos
, Trasplante de Médula Ósea/métodos
, Vacuna Antisarampión/uso terapéutico
, Sarampión/prevención & control
, Adolescente
, Adulto
, Anciano
, Niño
, Brotes de Enfermedades/prevención & control
, Humanos
, Esquemas de Inmunización
, Huésped Inmunocomprometido
, Inmunoglobulina G/sangre
, Inmunoglobulina G/química
, Inmunosupresores/farmacología
, Persona de Mediana Edad
, Infecciones Oportunistas/prevención & control
, Estudios Prospectivos
, Factores de Tiempo
, Acondicionamiento Pretrasplante/métodos
RESUMEN
Human herpesvirus-8 (HHV-8) appears to be transmitted mainly by sexual contact. However, several studies suggest that in developing countries the infection may be acquired early in life by routes other than sexual transmission. The present study estimated the seroprevalence of HHV-8 in Brazilian children born to HIV-1-infected mothers. The serum samples were collected in a cross-sectional cohort study from 99 children born to HIV-infected mothers (median age 3.27 years; range 1.5-13.8 years) attending the outpatient clinic of the Federal University of São Paulo. IgG antibodies to HHV-8 latency-associated nuclear antigen and lytic phase antigens were detected by immunofluorescence assays. The samples tested were collected from children aged 12 months or older to exclude the possibility of cross-placental antibody transport. The total prevalence of anti-lytic antibodies in this population (5/99; 5 percent) reveals that HHV-8 infection can occur during childhood. Children aged 1.5 to 2 years had a seroprevalence of 2 percent (1/50) and children aged 3.25 to 13.8 years had a seroprevalence of 8 percent (4/49). This difference was not statistically significant, probably because of the small size of the sample, but it suggests that HHV-8 infection occurs more commonly late in infancy. Further prospective studies are necessary to evaluate the timing and risk factors for primary HHV-8 infection in the pediatric population.
Asunto(s)
Humanos , Masculino , Femenino , Embarazo , Lactante , Preescolar , Niño , Adolescente , Infecciones por VIH/complicaciones , VIH-1 , Infecciones por Herpesviridae/epidemiología , /inmunología , Complicaciones Infecciosas del Embarazo/virología , Brasil/epidemiología , Estudios de Cohortes , Estudios Transversales , Técnica del Anticuerpo Fluorescente Directa , Anticuerpos Anti-VIH/sangre , Infecciones por Herpesviridae/diagnóstico , Infecciones por Herpesviridae/transmisión , Infecciones por Herpesviridae/virología , Transmisión Vertical de Enfermedad Infecciosa , Inmunoglobulina G/sangre , Sensibilidad y Especificidad , Estudios SeroepidemiológicosAsunto(s)
Masculino , Lactante , Preescolar , Niño , Adulto , Humanos , Infecciones por Herpesviridae/epidemiología , Herpesvirus Humano 8/inmunología , Anticuerpos Antivirales/sangre , Infecciones por Herpesviridae/transmisión , Infecciones por Herpesviridae/virología , Síndrome de Inmunodeficiencia Adquirida/virología , Sarcoma de Kaposi/virología , Homosexualidad Masculina , Técnica del Anticuerpo Fluorescente , Estudios Seroepidemiológicos , Latencia del Virus , Factores de Riesgo , Prevalencia , Brasil/epidemiologíaRESUMEN
Human herpesvirus 8 (HHV-8) is a newly described herpesvirus that is etiologically associated with all forms of Kaposi's sarcoma (KS). Seroepidemiological studies have shown high prevalence rates of HHV-8 antibodies among men who have sex with men (MSM) and AIDS patients, African children, Brazilian Amerindians, and elderly individuals in certain regions of Europe. The aim of the present study was to determine the prevalence of HHV-8 antibodies in healthy children and young adults from different cities in São Paulo State, and in a population at high risk for HHV-8 infection: HIV-negative MSM, and AIDS patients with and without KS. Antibodies to HHV-8 latency-associated nuclear antigen and lytic-phase antigens were detected by immunofluorescence assays. In 643 healthy children and young adults from the general population attending a vaccination program for yellow fever in ten different cities in São Paulo State, the prevalence of HHV-8 antibodies detected by the presence of latent or lytic antigens ranged from 1.0 to 4.1 percent in the different age groups (mean = 2.5 percent). In the MSM group, the prevalence was 31/95 (32.6 percent). In the group of patients with AIDS, the prevalence was 39.2 percent (51/130) for non-KS patients and 98.7 percent (77/78) for AIDS patients with the diagnosis of KS confirmed by histopathological examination. We conclude that HHV-8 has a restricted circulation among healthy children and young adults in the general population of São Paulo State and a high prevalence among MSM and AIDS patients.
Asunto(s)
Humanos , Masculino , Lactante , Preescolar , Niño , Adulto , Infecciones por Herpesviridae , Herpesvirus Humano 8 , Anticuerpos Antivirales , Sarcoma de Kaposi , Brasil , Estudios Seroepidemiológicos , Prevalencia , Factores de Riesgo , Técnica del Anticuerpo Fluorescente , Latencia del Virus , Infecciones por Herpesviridae , Homosexualidad Masculina , Síndrome de Inmunodeficiencia Adquirida/virologíaRESUMEN
Human herpesvirus 8 (HHV-8) is a newly described herpesvirus that is etiologically associated with all forms of Kaposi's sarcoma (KS). Seroepidemiological studies have shown high prevalence rates of HHV-8 antibodies among men who have sex with men (MSM) and AIDS patients, African children, Brazilian Amerindians, and elderly individuals in certain regions of Europe. The aim of the present study was to determine the prevalence of HHV-8 antibodies in healthy children and young adults from different cities in São Paulo State, and in a population at high risk for HHV-8 infection: HIV-negative MSM, and AIDS patients with and without KS. Antibodies to HHV-8 latency-associated nuclear antigen and lytic-phase antigens were detected by immunofluorescence assays. In 643 healthy children and young adults from the general population attending a vaccination program for yellow fever in ten different cities in São Paulo State, the prevalence of HHV-8 antibodies detected by the presence of latent or lytic antigens ranged from 1.0 to 4.1% in the different age groups (mean=2.5%). In the MSM group, the prevalence was 31/95 (32.6%). In the group of patients with AIDS, the prevalence was 39.2% (51/130) for non-KS patients and 98.7% (77/78) for AIDS patients with the diagnosis of KS confirmed by histopathological examination. We conclude that HHV-8 has a restricted circulation among healthy children and young adults in the general population of São Paulo State and a high prevalence among MSM and AIDS patients.